Enzo Biochem (NYSE: ENZ) reported Q4 EPS of $0.77, versus $0.18 reported last year. Revenue for the quarter came in at $26.6 million, versus $25.7 million reported last year.

For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.